Alzheimer Disease Cerebrospinal Fluid Biomarkers Moderate Baseline Differences and Predict Longitudinal Change in Attentional Control and Episodic Memory Composites in the Adult Children Study

OBJECTIVE: Cognitive measures that are sensitive to biological markers of Alzheimer disease (AD) pathology are needed in order to (a) facilitate preclinical staging, (b) identify individuals who are at the highest risk for developing clinical symptoms and (c) serve as endpoints for evaluating the ef...

Full description

Saved in:
Bibliographic Details
Published in:J Int Neuropsychol Soc
Main Authors: Aschenbrenner, Andrew J., Balota, David A., Fagan, Anne M., Duchek, Janet M., Benzinger, Tammie L.S., Morris, John C.
Format: Artigo
Language:Inglês
Published: 2015
Subjects:
Article
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC4610253/
https://ncbi.nlm.nih.gov/pubmed/26416094
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1017/S1355617715000776
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items